Table 3.
Covariates | Plasma leakage (N = 100) | Severe dengue (N = 152) | Intermediate severity (N = 169) | Uncomplicated dengue (N = 376) |
---|---|---|---|---|
Age | 1.02 [1.01–1.03] | 1.02 [1.01–1.03] | 1.00 [0.99–1.01] | 0.98 [0.97–0.99] |
Sex | ||||
Male | 4.97 [3.01–8.25] | 3.18 [2.14–4.72] | 0.49 [0.34–0.71] | 0.79 [0.56–1.08] |
Female | 1 | 1 | 1 | 1 |
Immune status | ||||
Primary | 1 | 1 | 1 | 1 |
Secondary | 2.08 [1.13–3.85] | 1.78 [1,09–2.89] | 1.22 [0.80–1.87] | 0.61 [0.42–0.89] |
Undetermined | 0.95 [0.42–2.17] | 0.83 [0.43–1.65] | 0.83 [0.45–1.52] | 1.30 [0.78–2.18] |
Serotype | ||||
DENV-1 | 1 | 1 | 1 | 1 |
DENV-2 | 2.14 [1.15–3.98] | 1.95 [1.16–3.29] | 0.77 [0.50–1.19] | 0.81 [0.55–1.22] |
DENV-4 | 0.58 [0.25–1.34] | 0.96 [0.52–1.80] | 0.45 [0.26–0.76] | 1.92 [1.21–3.05] |